Spring Eadv 2025. 7th eadv spring symposium (3693). Deucravacitinib is a selective, oral, allosteric tyrosine kinase 2 (tyk2).
Deucravacitinib is a selective, oral, allosteric tyrosine kinase 2 (tyk2). Eadv hosts two main events a.
Spring Eadv 2025 Images References :
